rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Grifols, S.A. - American Depositary Shares

GRFS · Nasdaq

Health CareBiotechnologySetting up

GRFS stood above a rising 150-day average in 2 of the last 52 weekly readings, and has been out of that trend for the last 50 weeks. It is 1.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 50
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
4
Institutions holding
161 (-18)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

4 disclosed lines: House 4, Senate 0, executive 0; 3 people.

WhoDidAmountTraded
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k31 Mar 2023filed 17 Apr 2023
Daniel S. Goldman House: U.S. House ClerkNY10bought$1k–$15k27 Feb 2023filed 20 Mar 2023
Greg Gianforte House: U.S. House ClerkMT00soldjoint$100k–$250k11 Nov 2019filed 23 Dec 2019
Donna E. Shalala House: U.S. House ClerkFL27sold$1k–$15k24 Jun 2019filed 27 Apr 2020

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders161-18 on the quarter
New · exited20 · 39
Reported value$1.0B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BRANDES INVESTMENT PARTNERS, LPadded · filed 14 Aug 202637,816,285$267.7M+1,482,571+4.1%
Capital World Investorsreduced · filed 12 Aug 202622,911,656$162.2M-13,334−0.1%
Permian Investment Partners, LPadded · filed 14 Aug 202619,740,679$139.8M+386,000+2.0%
Black Creek Investment Management Inc.reduced · filed 12 Aug 20267,682,055$54.4M-704,397−8.4%
BANK OF AMERICA CORPadded · filed 14 Aug 20266,550,337$46.4M+2,222,924+51.4%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 20264,369,934$30.9M-635,598−12.7%
Flat Footed LLCadded · filed 14 Aug 20264,349,708$30.8M+2,977,314+216.9%
Jupiter Topco LLCnew · filed 14 Aug 20262,958,981$20.9M+2,958,981
ARMISTICE CAPITAL, LLCreduced · filed 14 Aug 20262,936,000$20.8M-52,000−1.7%
MORGAN STANLEYreduced · filed 13 Aug 20262,661,180$18.8M-196,776−6.9%
31 Mar 2023 – 30 Jun 2026
112145177Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Daniel S. Goldman HouseNY10 · last 31 Mar 20231 · 1
Greg Gianforte HouseMT00 · last 11 Nov 20190 · 1
Donna E. Shalala HouseFL27 · last 24 Jun 20190 · 1

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

From its SEC filings

No ratio computed from its SEC filings yet.

Analyst forecasts

No analyst forecasts yet.